List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 80 studies with search of:   "thrombotic thrombocytopenic purpura" OR "Purpura, Thrombocytopenic"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention:
2 Recruiting Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: Rituximab
3 Recruiting Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Cyclosporine;   Drug: Prednisone
4 Terminated Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Uniplas
5 Not yet recruiting Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab
6 Not yet recruiting Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) (The STAR Study)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Rituximab;   Procedure: Plasma exchange;   Drug: Corticosteroids
7 Active, not recruiting AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Biological: AMG531;   Drug: Medical Standard of Care for ITP
8 Recruiting Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab
9 Recruiting Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
10 Completed Retrospective & Prospective Observational Study of Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Other: Retrospective Chart Review;   Other: Patient-reported Outcome Questionnaires;   Other: Physician Survey
11 Recruiting International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Conditions: Thrombotic Microangiopathy;   Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura
Intervention:
12 Completed An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Immune Thrombocytopenic Purpura
Intervention:
13 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
14 Recruiting An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenic Purpura
Intervention: Biological: Romiplostim
15 Recruiting Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathy;   Thrombotic Thrombocytopenic Purpura
Interventions: Drug: ARC 1779 Placebo;   Drug: ARC1779 Injection;   Drug: ARC1779 Injection;   Drug: ARC1779 Injection
16 Active, not recruiting Pilot Study of R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: R935788
17 Recruiting Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab;   Drug: Placebo
18 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
19 Recruiting Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: lansoprazole, clarithromycin, amoxycillin
20 Recruiting Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
Condition: Autoimmune Thrombocytopenic Purpura
Intervention: Drug: Doxil

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services